International Prostate Symptom Score for benign prostatic hyperplasia (Barry 1992).

What it is and when to use it

The IPSS (International Prostate Symptom Score) is a self-administered questionnaire that quantifies the severity of lower urinary tract symptoms (LUTS) in men, typically associated with benign prostatic hyperplasia. It comprises 7 questions assessing symptoms (incomplete emptying, frequency, intermittency, urgency, weak stream, straining and nocturia), each scored 0 to 5, for a total of 0 to 35; a separate eighth question assesses quality of life (0 to 6) and is not counted within the symptom score. It is the instrument recommended by the EAU (European Association of Urology) and AUA guidelines for the initial assessment and follow-up of male LUTS (it is identical to the AUA-SI with the quality-of-life question added).

How to interpret it

The symptom score (0-35) is classified into three bands: 0-7 mild symptoms, 8-19 moderate symptoms and 20-35 severe symptoms. Mild symptoms usually allow watchful waiting; moderate and severe scores point toward medical therapy or, depending on response and complications, surgery. The separate quality-of-life question (bother index, 0=delighted to 6=terrible) is not added to the total but is key to deciding treatment intensity, since two patients with the same score may tolerate their symptoms very differently.

Limitations and when not to use it

Validated in men with LUTS/suspected benign prostatic hyperplasia. It is neither diagnostic nor specific: a high score does not confirm a prostatic origin, since infection, overactive bladder, neurogenic bladder dysfunction, prostatitis or causes in women can yield similar scores. It does not assess prostate cancer and does not replace PSA, digital rectal examination, uroflowmetry or ultrasound. It requires adequate literacy and comprehension and may be unreliable with language barriers or cognitive impairment. Its main value is longitudinal monitoring of treatment response within the same patient.

Frequently asked questions

What IPSS score is considered severe?

A total symptom score of 20 to 35 is considered severe; 8-19 is moderate and 0-7 is mild.

Can the IPSS diagnose prostate cancer?

No. The IPSS only measures the severity of urinary symptoms and does not detect cancer; screening requires PSA, digital rectal examination and urological assessment.

Is the quality-of-life question counted in the IPSS total?

No. The quality-of-life question is scored separately (0-6) and is not added to the 0-35 total, but it helps guide treatment decisions.